EyeBrain researchers move into Brain and Spine Institute

16 July 2012

EyeBrain, a company developing medical devices for the early diagnosis and monitoring of neurological diseases, has moved one of its scientific teams into the premises of the Brain and Spine Institute (Institut du Cerveau et de la Moelle Epiniere - ICM) at the Pitie-Salpetriere hospital in Paris.

The aim is to foster scientific exchange with ICM researchers and speed up the development of clinical research tools for neurological diseases.

The ICM is an international center of excellence specialized in research into neurological diseases. It selected EyeBrain for its know-how in the analysis of eye movements. Depending on any abnormalities detected, these movements make it possible to determine which regions of the brain are not functioning correctly and to reach an early diagnosis of the disease.

By moving a research team into the ICM's premises, EyeBrain will have the benefit of 600 researchers and 22,000 square meters of laboratory space that houses patients, doctors and researchers under the same roof. This will enable EyeBrain to work on the development of innovative new devices for diagnosing neurological diseases.

"We welcome the arrival of EyeBrain, a young firm that developed its first product thanks to a research collaboration with researchers from our institute," said Alexis Genin, the ICM's research applications director. "We are convinced that the company's location within the ICM will speed up the development of useful new devices for the early diagnosis of nervous system diseases."

"Our move into the ICM reflects the medical world's strong recognition of EyeBrain's knowhow," said Magali Seassau. "We are delighted to become part of this prestigious establishment, where we will be able to exploit the many existing synergies between our respective researchers and to develop and validate our new products more easily and more quickly."

One in eight people is affected by neurological diseases, which are characterized by lesional eruptions on the brain, the spinal cord, the peripheral nerves or the muscles. They are often chronic and incapacitating conditions that require extensive medical treatment and social care. Clinical research in the field of neurosciences is a major challenge for the treatment of patients, from diagnosis to disease monitoring and action to improve their quality of life.


To top